Navigation Links
Study in NEJM Shows Novartis Drug Afinitor® Reduces Size of SEGAs, Benign Brain Tumors Associated with Tuberous Sclerosis
Date:11/3/2010

EAST HANOVER, N.J., Nov. 3, 2010 /PRNewswire/ -- The New England Journal of Medicine (NEJM) today published a study that found patients taking Afinitor® (everolimus) tablets experienced a decrease in the size of their subependymal giant cell astrocytoma (SEGA), a benign brain tumor associated with tuberous sclerosis (TS)(1,2). This study, which was previously presented at the 46th American Society of Clinical Oncology annual meeting, is the first prospective clinical trial of a drug to show treatment benefit in these patients.

Tuberous sclerosis is a genetic disorder that is estimated to affect 25,000 to 40,000 people in the US and may cause benign tumors to form in vital organs(3). SEGAs, benign brain tumors, occur in up to 20% of patients with TS and primarily affect children and adolescents(1,4,5). SEGAs may pose a significant medical risk, including the potential for swelling in the brain, or hydrocephalus(1).

According to data published in NEJM from this Phase I/II study of 28 patients conducted by Cincinnati Children's Hospital Medical Center, treatment with everolimus was associated with a significant reduction in primary SEGA volume at six months relative to baseline on independent central review (p<0.001). Seventy-five percent of patients (21 of 28) experienced a reduction of 30% or greater in the size of their largest SEGA and 32% (9 of 28) experienced a reduction of 50% or greater at six months relative to baseline(2).

The published study findings also showed that in nine of 16 patients, everolimus therapy was associated with a reduction from baseline to six months in overall frequency of seizures per 24 hour video electroencephalograms (EEG) (n=16; median change -1 seizure, p=0.022). Additionally, no patients required surgery or developed a new SEGA while receiving everolimus(2).

The most common adverse reactions observed (incidence greater than or equal to 30%) in this trial were mouth sores,
'/>"/>

SOURCE Novartis
Copyright©2010 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... 22, 2013 /PRNewswire-iReach/ -- MarketReportsOnline.com announces addition of ... Series (4) 2013 Edition Material and Clinical Trial ... Registration: A Guidebook of Registration Application for Imported ... its online database. The traditional medicines ... always regarded by occidental as mysterious medicines. Until ...
(Date:5/22/2013)... 22, 2013 Assured Pharmacy, Inc. (APHY), a ... to sufferers of chronic pain, announced it has engaged ... relations firm, to raise its visibility and strengthen its ... past year, we have proven our business model and ... to open two additional new pharmacies in ...
(Date:5/22/2013)... TEL AVIV, Israel , May 22, 2013 /PRNewswire/ ... "Company") (TASE, NASDAQ: EMITF) announced today, further to the ... filed a motion with the Tel Aviv ... of its unsecured creditors and shareholders for the approval ... debt pursuant to a plan of arrangement (the "Arrangement") ...
Breaking Medicine Technology:China Pharmaceutical Market Guidebook Series (4) 2013 Report 2China Pharmaceutical Market Guidebook Series (4) 2013 Report 3China Pharmaceutical Market Guidebook Series (4) 2013 Report 4China Pharmaceutical Market Guidebook Series (4) 2013 Report 5Assured Pharmacy Hires Hayden IR 2Assured Pharmacy Hires Hayden IR 3Elbit Imaging Announces the Court Decision with Respect to Filing of Plan of Arrangement with the Israeli Court 2Elbit Imaging Announces the Court Decision with Respect to Filing of Plan of Arrangement with the Israeli Court 3
... 1, 2011 CMC Biologics today announced the completion ... (2,000L SUB) at its manufacturing facility in Copenhagen. The ... Biologics has in its manufacturing facilities in Copenhagen and ... be ready for GMP contract manufacturing by December 2011. ...
... R.I., Sept. 1, 2011 The CVS Caremark Charitable ... today a donation of $75,000 to the American Red ... the east coast of the United States impacted by ... in free water, ice and other supplies to local ...
Cached Medicine Technology:CMC Biologics Adds 2,000 Liter Single-Use Bioreactor at its Copenhagen Manufacturing Facility 2CVS Caremark Charitable Trust and CVS/pharmacy Provide Over $100,000 in Disaster Relief To Communities Impacted by Hurricane Irene 2
(Date:5/22/2013)... -- Roughly four in 10 uninsured patients who have ... do not have the lung disease, a small new ... based on an evaluation of symptoms, rather than by ... as spirometry, which shows how well a patient,s lungs ... can exhale and how long that takes. ...
(Date:5/22/2013)... 2013, Paris, France: Results from a large ... question whether bivalirudin is superior to heparin ... similar 30-day mortality in patients with non-ST ... percutaneous coronary intervention (PCI)., European and US ... an alternative to unfractionated heparin plus GP ...
(Date:5/22/2013)... Seva Call (Save-A-Call) has launched in Detroit, ... connects consumers to the right available professional by phone ... handle personal matters than the national and state average ... So, they really can’t afford the 30 minutes most ... , Now, Detroit residents will be able to hear ...
(Date:5/22/2013)... LDM Global ( http://www.ldmglobal.com ) a ... law firms, corporations and government agencies announces that it ... software company, to deliver defensible ESI collections with eCloudCollect. ... Data and LDM Global hosted a VIP Happy Hour ... 21st. This event was in conjunction with LegalTech ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Many people ... looking for education on how to lose weight safely ... be challenging and may demotivate people to continue their ... study discussed this week on Medical News Today ... how to lose weight and actually losing those initial ...
Breaking Medicine News(10 mins):Health News:COPD May Be Over-Diagnosed Among Uninsured 2Health News:Registry questions superiority of bivalirudin over heparin 2Health News:Seva Call Revs Its Engines to Launch in Motor City 2Health News:LDM Global Enhances Forensic Data Collection Services with eCloudCollect 2Health News:LDM Global Enhances Forensic Data Collection Services with eCloudCollect 3Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Break the Cycle of Obesity and Weight Gain With New Education For Patients on How to Lose Weight the Healthy Way 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Break the Cycle of Obesity and Weight Gain With New Education For Patients on How to Lose Weight the Healthy Way 3
... sponge like particles may come to the therapeutic aid ... Brian Saunders from The School of Materials// and Professor ... Sciences. ,The tiny gel particles discovered by ... injected into the damaged region. This study was performed ...
... paucity of anesthesiologists in the province of Ontario, evident in ... tide over such a situation, Ontario has created two additional ... times for patients. This strategy has proved its weight in ... time tested measure to improve patient care. ...
... least two servings of fruits and three servings of ... Americans are not eating enough fruits and vegetables. This ... diet high in fruits and vegetables is associated with ... as cardiovascular disease, diabetes and some cancers. ...
... Organization estimates that nearly nine million people around the ... year//. The bacterium behind the notorious lung disease was ... 125th anniversary on March 24th, also The World Tuberculosis ... the disease is vanquished. ,Experts are particularly ...
... and figures has shown the dangerous increase in Type 1 ... number of children below five years of age, battling the ... 1985 and 2004. ,Type 1 diabetes or insulin ... opposed to Type 2 diabetes, which develops much later. According ...
... southern Indian state of Kerala, have said that "chance inhalation" ... of the three partying youngsters, including a girl in December last. ... a closed garage, by the side of a car parked there. ... ,The police now say that the youngsters had pulled ...
Cached Medicine News:Health News:Eat Fruits- Keep Diseases at Bay 2Health News:Eat Fruits- Keep Diseases at Bay 3Health News:Kerala Youth Die of Carbon Monoxide Inhalation 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: